Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk

Stephan Weidinger, Hansjoerg Baurecht, Stefan Wagenpfeil, John Henderson, Natalija Novak, Aileen Sandilands, Huijia Chen, Elke Rodriguez, Grainne M. O'Regan, Rosemarie Watson, Haihui Liao, Yiwei Zhao, Jonathan N. W. N. Barker, Michael Allen, Nick Reynolds, Simon Meggitt, Kate Northstone, George D. Smith, Carolin Strobl, Caroline StahlThomas Kneib, Norman Klopp, Thomas Bieber, Heidrun Behrendt, Colin N. A. Palmer, H. -Erich Wichmann, Johannes Ring, Thomas Illig, W. H. Irwin McLean, Alan D. Irvine

    Research output: Contribution to journalArticlepeer-review

    69 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk'. Together they form a unique fingerprint.

    Medicine & Life Sciences